ARTICLE | Clinical News
Lymphoseek tilmanocept regulatory update
November 19, 2012 8:00 AM UTC
Navidea said FDA accepted for review the resubmission of an NDA for Lymphoseek tilmanocept for use in intraoperative lymphatic imaging. The agency designated the resubmission as a class 2 response, wi...